Nivagen Pharmaceuticals News and Resources

Nivagen Pharmaceuticals, Inc. has announced the sale of its MedisourceRx business unit to Hims & Hers Health, Inc.. The sale is part of a broader strategic plan by Nivagen to enhance its manufacturing capabilities. MedisourceRx, an FDA-registered 503B outsourcing facility,